Dechra quarterly revenues up 5.1%

6th Nov 2009 07:57

Dechra Pharmaceuticals, which focuses on the veterinary sector, has started the financial year in line with expectations with revenue in the first quarter 5.1% ahead of last year. The pharmaceuticals division has continued to make good progress with first quarter revenue 11% higher than the equivalent period last year. Vetoryl sales into distributors in the US in the period were $1.2m. Sales into veterinary practices in the US are reflecting month on month growth and in September 2009 were almost $0.5m, a 25% increase over sales achieved in June 2009.The Services Division achieved first quarter revenue growth of 3.3%. National Veterinary Services maintained its operating margin at the level achieved in the financial year ended 30 June 2009.'The board remains confident that the group will continue to make good strategic progress in line with management expectations throughout the remainder of the financial year,' it said.